Groupe Hospitalier Pellegrin ( Site 2218)

Bordeaux, Gironde 33000

0 studies enrolling now · 1 studies all time

What they study most

Respiratory Syncytial Virus Infection

Studies at this site

• Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004) — Completed